Keyword Index

A

  • Acute on chronic liver failure Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]

C

  • Chronic hepatitis Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Chronic hepatitis C Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • COVID-19 Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • Cytokeratin-18 Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]

D

  • Direct acting antivirals Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]

H

  • Hepatocellular carcinoma Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]

P